These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 9279106)

  • 21. [Analysis of oncogenes and tumor suppressor genes].
    Sekiya T
    Tanpakushitsu Kakusan Koso; 1993 Feb; 38(3):314-20. PubMed ID: 8488265
    [No Abstract]   [Full Text] [Related]  

  • 22. [2000 Standards, Options and Recommendations for prognostic value of oncogenes and tumor suppressor genes in non small cell lung cancer].
    Bréchot JM; Molina T; Theobald S; Depierre A; Lagrange JL; Astoul P; Baldeyrou P; Bardet E; Bazelly B; Breton JL; Douillard JY; Grivaux M; Jacoulet P; Khalil A; Lemarié E; Martinet Y; Massard G; Milleron B; Moro-Sibilot D; Paesmans M; Pujol JL; Quoix AE; Ranfaing E; Rivière A; Sancho-Garnier H; Souquet PJ; Spaeth D; Stcebner-Delbarre A;
    Bull Cancer; 2002 Oct; 89(10):857-67. PubMed ID: 12441277
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chemical-induced genetic alterations in human cancers: relevance to aetiology and pathogenesis.
    Montesano R; Hainaut P; Hall J
    Eur J Cancer Prev; 1996 Oct; 5(5):392-3. PubMed ID: 8972271
    [No Abstract]   [Full Text] [Related]  

  • 24. Molecular genetic tumor markers in non-small cell lung cancer.
    Oyama T; Osaki T; Baba T; Nagata Y; Mizukami M; So T; Nakata S; Ichiki Y; Uramoto H; Sugaya M; Yoshimatsu T; Morita M; Hanagiri T; Sugio K; Kawamoto T; Yasumoto K
    Anticancer Res; 2005; 25(2B):1193-6. PubMed ID: 15865065
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Genetic alterations and genetic diagnosis of human cancer].
    Nakamura Y
    Tanpakushitsu Kakusan Koso; 1997 Jul; 42(10 Suppl):1711-5. PubMed ID: 9279103
    [No Abstract]   [Full Text] [Related]  

  • 26. [Hereditary tumor].
    Miki Y; Nakamura Y
    Tanpakushitsu Kakusan Koso; 1997 Jul; 42(10 Suppl):1716-22. PubMed ID: 9279104
    [No Abstract]   [Full Text] [Related]  

  • 27. Characterization of a multiple epigenetic marker panel for lung cancer detection and risk assessment in plasma.
    Hsu HS; Chen TP; Hung CH; Wen CK; Lin RK; Lee HC; Wang YC
    Cancer; 2007 Nov; 110(9):2019-26. PubMed ID: 17876837
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Telomere and telomerase in lung cancer].
    Hiyama K; Hiyama E
    Nihon Rinsho; 2002 May; 60 Suppl 5():737-42. PubMed ID: 12101775
    [No Abstract]   [Full Text] [Related]  

  • 29. [Bronchial cancer. Mechanisms of bronchial oncogenesis].
    Krespine C
    Soins; 1994 Dec-1995 Jan; (591-592):3-4, 6. PubMed ID: 7652603
    [No Abstract]   [Full Text] [Related]  

  • 30. [Progress in oncogenes and anti-cancer genes in lung cancer].
    Guo X; Deng W; Huang S
    Zhonghua Jie He He Hu Xi Za Zhi; 1995 Oct; 18(5):267-9. PubMed ID: 8762477
    [No Abstract]   [Full Text] [Related]  

  • 31. Genomic organization and mutation analysis of Hel-N1 in lung cancers with chromosome 9p21 deletions.
    Cairns P; Okami K; King P; Bonacum J; Ahrendt S; Wu L; Mao L; Jen J; Sidransky D
    Cancer Res; 1997 Dec; 57(23):5356-9. PubMed ID: 9393760
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Homozygous deletions at chromosome 9p21 and mutation analysis of p16 and p15 in microdissected primary non-small cell lung cancers.
    Packenham JP; Taylor JA; White CM; Anna CH; Barrett JC; Devereux TR
    Clin Cancer Res; 1995 Jul; 1(7):687-90. PubMed ID: 9816033
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lung cancer-related genes in the blood.
    Sonobe M; Tanaka F; Wada H
    Ann Thorac Cardiovasc Surg; 2004 Aug; 10(4):213-7. PubMed ID: 15458371
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic alterations of multiple tumor suppressors and oncogenes in the carcinogenesis and progression of lung cancer.
    Osada H; Takahashi T
    Oncogene; 2002 Oct; 21(48):7421-34. PubMed ID: 12379883
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Biological perspectives].
    Pujol JL; Demoly P; Quantin X; Simony J; Parrat E; Lehmann M; Daurès JP; Jolimoy G; Grenier J; Pau B; Godard P
    Rev Mal Respir; 1998 Jun; 15(3 Pt 2):428-40. PubMed ID: 9690313
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Oncogenes and tumor suppressor genes in lung cancer: research and trends].
    Wang M; Zhang G
    Zhonghua Jie He He Hu Xi Za Zhi; 1998 May; 21(5):261-2. PubMed ID: 11326945
    [No Abstract]   [Full Text] [Related]  

  • 37. [Immunohistochemistry of biomolecular markers of lung cancer].
    Kogan EA; Zhak G; Kaĭzer U; Shilli M; Shurman M; Sherer A; Khavemann K
    Arkh Patol; 1997; 59(6):23-30. PubMed ID: 9483214
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The laboratory in the diagnosis of pancreatic cancer].
    Boadas Mir J; Mora J; Farré Viladrich A
    Gastroenterol Hepatol; 1999 Nov; 22(9):456-60. PubMed ID: 10638044
    [No Abstract]   [Full Text] [Related]  

  • 39. New advances in the molecular biology of musculoskeletal neoplasms.
    Morcuende JA; Buckwalter JA
    Iowa Orthop J; 1997; 17():115-20. PubMed ID: 9234983
    [No Abstract]   [Full Text] [Related]  

  • 40. Expression of telomerase hTERT in human non-small cell lung cancer and its correlation with c-myc gene.
    Geng Z; Zhang D; Liu Y
    Chin Med J (Engl); 2003 Oct; 116(10):1467-70. PubMed ID: 14570602
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.